Ketamine Terminated Phase 2 Trials for Obsessive Compulsive Disorder (OCD) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02234011A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder